|
KMID : 1148920170510010022
|
|
Nuclear Medicine and Molecular Imaging
2017 Volume.51 No. 1 p.22 ~ p.31
|
|
|
FDG Whole-Body PET/MRI in Oncology: a Systematic Review
|
|
Kwon Hyun-Woo
Becker Ann Katharina
Goo Jin-Mo
Cheon Gi-Jeong
|
|
|
Abstract
|
|
|
|
The recent advance in hybrid imaging techniques enables offering simultaneous positron emission tomography (PET)/magnetic resonance imaging (MRI) in various clinical fields. 18F-fluorodeoxyglucose (FDG) PET has been widely used for diagnosis and evaluation of oncologic patients. The growing evidence from research and clinical experiences demonstrated that PET/MRI with FDG can provide comparable or superior diagnostic performance more than conventional radiological imaging such as computed tomography (CT), MRI or PET/CT in various cancers. Combined analysis using structural information and functional/molecular information of tumors can draw additional diagnostic information based on PET/MRI. Further studies including determination of the diagnostic efficacy, optimizing the examination protocol, and analysis of the hybrid imaging results is necessary for extending the FDG PET/MRI application in clinical oncology.
|
|
|
KEYWORD
|
|
|
FDG, Oncology, PET/MRI, Positron emission tomography/magnetic resonance imaging
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|